$AHG News

Akso Health Group shares are trading higher after the company initiated an R&D program for its proprietary brain-computer interface technology.

Akso Health Group shares are trading higher after the company initiated an R&D program for its proprietary brain-computer interface technology.

Reported Earlier: Akso Health Launches Early-Stage Brain-Computer Interface R&D Program; Has Not Commenced Any Human Clinical Trials, Has Not Made Any Regulatory Submissions To The FDA Or Any Other Regulatory Authority, And Is Not Generating Any Revenue From BCI-Related Activities

Pure Energy Announces Completion of an Earn-In Transaction in Esmeralda County

Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative

12 Health Care Stocks Moving In Thursday's After-Market Session

While Akso Health Group (NASDAQ:AHG) shareholders have made 235% in 3 years, increasing losses might now be front of mind as stock sheds 10% this week

Why Akso Health Group (AHG) Faces Uncertainty After Auditor Flags Doubt on Financial Viability

12 Health Care Stocks Moving In Friday's After-Market Session

Palo Alto Networks, Take-Two Interactive Software, VF Corp And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Akso Health Group (NASDAQ:AHG) investors are sitting on a loss of 27% if they invested three years ago

AHG Utilizes DeepSeek to Advance AI in Healthcare

Akso Health Group Announces Integration Of DeepSeek AI Technology To Enhance Medical Consultation And Resource Allocation

Estimating The Intrinsic Value Of Akso Health Group (NASDAQ:AHG)

Pure Energy Minerals Leadership Update and Future Plans

Akso Health Group (NASDAQ:AHG) shareholders are up 24% this past week, but still in the red over the last five years

Pure Energy Expands Lithium Exploration in Nevada

Akso Health Group Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.58 loss in FY 2023)